TreeWAS – Variant ID: rs114685215

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter II Neoplasms	0.908	0.092
D10-D36 Benign neoplasms	0.905	0.095
# Top node	0.902	0.098
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.892	0.108
D25 Leiomyoma of uterus	0.884	0.116
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.882	0.118
Chapter X Diseases of the respiratory system	0.876	0.124
D25.9 Leiomyoma of uterus, unspecified	0.852	0.148
D17 Benign lipomatous neoplasm	0.852	0.148
D70-D77 Other diseases of blood and blood-forming organs	0.834	0.166
C64-C68 Malignant neoplasms of urinary tract	0.834	0.166
Chapter IV Endocrine, nutritional and metabolic diseases	0.833	0.167
D60-D64 Aplastic and other anaemias	0.816	0.184
J90-J94 Other diseases of pleura	0.800	0.200
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.787	0.213
J20-J22 Other acute lower respiratory infections	0.787	0.213
D00-D09 In situ neoplasms	0.786	0.214
Chapter VII Diseases of the eye and adnexa	0.786	0.214
D24 Benign neoplasm of breast	0.785	0.215
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.781	0.219
C67 Malignant neoplasm of bladder	0.778	0.222
D27 Benign neoplasm of ovary	0.774	0.226
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.773	0.227
D25.1 Intramural leiomyoma of uterus	0.765	0.235
C51-C58 Malignant neoplasms of female genital organs	0.765	0.235
D70 Agranulocytosis	0.761	0.239
S80-S89 Injuries to the knee and lower leg	0.758	0.242
J40-J47 Chronic lower respiratory diseases	0.758	0.242
J90 Pleural effusion, not elsewhere classified	0.746	0.254
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.742	0.258
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.733	0.267
D25.2 Subserosal leiomyoma of uterus	0.732	0.268
D64 Other anaemias	0.732	0.268
J22 Unspecified acute lower respiratory infection	0.723	0.277
J95-J99 Other diseases of the respiratory system	0.722	0.278
D23 Other benign neoplasms of skin	0.721	0.279
E10-E14 Diabetes mellitus	0.720	0.280
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.719	0.281
Chapter VIII Diseases of the ear and mastoid process	0.714	0.286
T36-T50 Poisoning by drugs, medicaments and biological substances	0.713	0.287
D80-D89 Certain disorders involving the immune mechanism	0.710	0.290
S60-S69 Injuries to the wrist and hand	0.707	0.293
C67.9 Bladder, unspecified	0.705	0.295
J44 Other chronic obstructive pulmonary disease	0.703	0.297
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.700	0.300
S40-S49 Injuries to the shoulder and upper arm	0.698	0.302
Chapter XX External causes of morbidity and mortality	0.697	0.303
H30-H36 Disorders of choroid and retina	0.696	0.304
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.696	0.304
D37-D48 Neoplasms of uncertain or unknown behaviour	0.695	0.304
J80-J84 Other respiratory diseases principally affecting the interstitium	0.694	0.305
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.688	0.312
C78.0 Secondary malignant neoplasm of lung	0.688	0.312
T66-T78 Other and unspecified effects of external causes	0.683	0.317
S20-S29 Injuries to the thorax	0.679	0.321
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.676	0.323
D22 Melanocytic naevi	0.672	0.328
D64.9 Anaemia, unspecified	0.672	0.328
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.668	0.332
Chapter XXII Codes for special purposes	0.666	0.334
D18 Haemangioma and lymphangioma, any site	0.665	0.335
D50-D53 Nutritional anaemias	0.664	0.336
D61 Other aplastic anaemias	0.663	0.337
Chapter V Mental and behavioural disorders	0.661	0.339
C67.2 Lateral wall of bladder	0.660	0.340
D75 Other diseases of blood and blood-forming organs	0.660	0.340
S50-S59 Injuries to the elbow and forearm	0.659	0.340
S00-S09 Injuries to the head	0.659	0.341
E70-E90 Metabolic disorders	0.656	0.344
D05 Carcinoma in situ of breast	0.652	0.348
D73 Diseases of spleen	0.651	0.349
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.651	0.349
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.651	0.349
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.651	0.349
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.651	0.349
C40-C41 Malignant neoplasms of bone and articular cartilage	0.651	0.349
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.651	0.349
C56 Malignant neoplasm of ovary	0.650	0.350
D35 Benign neoplasm of other and unspecified endocrine glands	0.649	0.351
D33 Benign neoplasm of brain and other parts of central nervous system	0.649	0.351
D31 Benign neoplasm of eye and adnexa	0.649	0.351
D30 Benign neoplasm of urinary organs	0.649	0.351
D29 Benign neoplasm of male genital organs	0.649	0.351
D28 Benign neoplasm of other and unspecified female genital organs	0.649	0.351
D26 Other benign neoplasms of uterus	0.649	0.351
D21 Other benign neoplasms of connective and other soft tissue	0.649	0.351
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.649	0.351
D19 Benign neoplasm of mesothelial tissue	0.649	0.351
D16 Benign neoplasm of bone and articular cartilage	0.649	0.351
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.649	0.351
D14 Benign neoplasm of middle ear and respiratory system	0.649	0.351
D10 Benign neoplasm of mouth and pharynx	0.649	0.351
D34 Benign neoplasm of thyroid gland	0.649	0.351
C78.2 Secondary malignant neoplasm of pleura	0.648	0.352
Chapter XVI Certain conditions originating in the perinatal period	0.647	0.353
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.644	0.356
H53-H54 Visual disturbances and blindness	0.643	0.357
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.643	0.357
S90-S99 Injuries to the ankle and foot	0.641	0.359
D55-D59 Haemolytic anaemias	0.640	0.360
E20-E35 Disorders of other endocrine glands	0.639	0.361
S82 Fracture of lower leg, including ankle	0.638	0.362
D32 Benign neoplasm of meninges	0.637	0.363
E16 Other disorders of pancreatic internal secretion	0.637	0.363
Chapter XI Diseases of the digestive system	0.635	0.365
S70-S79 Injuries to the hip and thigh	0.634	0.366
D09 Carcinoma in situ of other and unspecified sites	0.633	0.366
T79-T79 Certain early complications of trauma	0.632	0.368
T33-T35 Frostbite	0.632	0.368
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.632	0.368
T26-T28 Burns and corrosions confined to eye and internal organs	0.632	0.368
T20-T25 Burns and corrosions of external body surface, specified by site	0.632	0.368
T15-T19 Effects of foreign body entering through natural orifice	0.632	0.368
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.632	0.368
T00-T07 Injuries involving multiple body regions	0.632	0.368
S10-S19 Injuries to the neck	0.632	0.368
D36 Benign neoplasm of other and unspecified sites	0.632	0.368
J09-J18 Influenza and pneumonia	0.632	0.368
D17.6 Benign lipomatous neoplasm of spermatic cord	0.629	0.371
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.628	0.372
E10 Insulin-dependent diabetes mellitus	0.628	0.372
C60-C63 Malignant neoplasms of male genital organs	0.628	0.372
H35 Other retinal disorders	0.625	0.374
E50-E64 Other nutritional deficiencies	0.624	0.376
D11 Benign neoplasm of major salivary glands	0.623	0.377
H52 Disorders of refraction and accommodation	0.620	0.380
J43 Emphysema	0.620	0.380
D23.1 Skin of eyelid, including canthus	0.620	0.380
J60-J70 Lung diseases due to external agents	0.615	0.384
K65-K67 Diseases of peritoneum	0.615	0.385
D17.9 Benign lipomatous neoplasm, unspecified	0.611	0.389
D17.7 Benign lipomatous neoplasm of other sites	0.611	0.389
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.611	0.389
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.611	0.389
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.607	0.393
C64 Malignant neoplasm of kidney, except renal pelvis	0.606	0.394
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.598	0.402
D74 Methaemoglobinaemia	0.598	0.402
D72 Other disorders of white blood cells	0.598	0.402
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.598	0.402
D71 Functional disorders of polymorphonuclear neutrophils	0.598	0.402
C68 Malignant neoplasm of other and unspecified urinary organs	0.598	0.402
C66 Malignant neoplasm of ureter	0.598	0.402
C65 Malignant neoplasm of renal pelvis	0.598	0.402
E40-E46 Malnutrition	0.597	0.402
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.597	0.403
H90-H95 Other disorders of ear	0.596	0.404
K66 Other disorders of peritoneum	0.593	0.406
D23.6 Skin of upper limb, including shoulder	0.593	0.407
D05.9 Carcinoma in situ of breast, unspecified	0.592	0.408
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.591	0.409
S81 Open wound of lower leg	0.590	0.410
J98 Other respiratory disorders	0.589	0.411
D69 Purpura and other haemorrhagic conditions	0.586	0.414
Chapter XII Diseases of the skin and subcutaneous tissue	0.586	0.414
D63 Anaemia in chronic diseases classified elsewhere	0.586	0.414
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.585	0.415
D62 Acute posthaemorrhagic anaemia	0.585	0.415
D86 Sarcoidosis	0.580	0.420
J44.8 Other specified chronic obstructive pulmonary disease	0.579	0.421
K66.0 Peritoneal adhesions	0.578	0.422
E16.2 Hypoglycaemia, unspecified	0.578	0.422
J44.9 Chronic obstructive pulmonary disease, unspecified	0.575	0.425
D07 Carcinoma in situ of other and unspecified genital organs	0.575	0.425
H35.3 Degeneration of macula and posterior pole	0.574	0.426
J94 Other pleural conditions	0.573	0.426
J92 Pleural plaque	0.573	0.426
J91 Pleural effusion in conditions classified elsewhere	0.573	0.426
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.573	0.427
D68 Other coagulation defects	0.572	0.428
C54 Malignant neoplasm of corpus uteri	0.572	0.428
S82.8 Fractures of other parts of lower leg	0.572	0.428
S80 Superficial injury of lower leg	0.570	0.430
J93 Pneumothorax	0.570	0.430
H60-H62 Diseases of external ear	0.568	0.432
J42 Unspecified chronic bronchitis	0.568	0.432
K20-K31 Diseases of oesophagus, stomach and duodenum	0.568	0.432
D06 Carcinoma in situ of cervix uteri	0.564	0.436
J21 Acute bronchiolitis	0.564	0.436
J20 Acute bronchitis	0.564	0.436
D04 Carcinoma in situ of skin	0.564	0.436
D03 Melanoma in situ	0.564	0.436
D02 Carcinoma in situ of middle ear and respiratory system	0.564	0.436
D01 Carcinoma in situ of other and unspecified digestive organs	0.564	0.436
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.564	0.436
H55-H59 Other disorders of eye and adnexa	0.563	0.437
H46-H48 Disorders of optic nerve and visual pathways	0.563	0.437
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.563	0.437
H10-H13 Disorders of conjunctiva	0.563	0.437
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.561	0.439
E11 Non-insulin-dependent diabetes mellitus	0.561	0.439
S61 Open wound of wrist and hand	0.561	0.439
C80 Malignant neoplasm without specification of site	0.560	0.440
C76 Malignant neoplasm of other and ill-defined sites	0.560	0.440
K30 Dyspepsia	0.559	0.441
S40 Superficial injury of shoulder and upper arm	0.558	0.442
C67.8 Overlapping lesion of bladder	0.558	0.442
C67.7 Urachus	0.558	0.442
C67.6 Ureteric orifice	0.558	0.442
C67.5 Bladder neck	0.558	0.442
C67.4 Posterior wall of bladder	0.558	0.442
C67.3 Anterior wall of bladder	0.558	0.442
C67.1 Dome of bladder	0.558	0.442
C67.0 Trigone of bladder	0.558	0.442
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.558	0.442
J80 Adult respiratory distress syndrome	0.555	0.444
D61.9 Aplastic anaemia, unspecified	0.554	0.446
J95 Postprocedural respiratory disorders, not elsewhere classified	0.553	0.447
E65-E68 Obesity and other hyperalimentation	0.552	0.448
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.551	0.449
C34 Malignant neoplasm of bronchus and lung	0.551	0.449
T51 Toxic effect of alcohol	0.550	0.450
C57 Malignant neoplasm of other and unspecified female genital organs	0.548	0.451
C53 Malignant neoplasm of cervix uteri	0.548	0.451
C51 Malignant neoplasm of vulva	0.548	0.451
C58 Malignant neoplasm of placenta	0.548	0.451
C55 Malignant neoplasm of uterus, part unspecified	0.548	0.451
C52 Malignant neoplasm of vagina	0.548	0.451
D23.7 Skin of lower limb, including hip	0.544	0.456
S68 Traumatic amputation of wrist and hand	0.543	0.456
S89 Other and unspecified injuries of lower leg	0.543	0.456
S88 Traumatic amputation of lower leg	0.543	0.456
S87 Crushing injury of lower leg	0.543	0.456
S86 Injury of muscle and tendon at lower leg level	0.543	0.456
S85 Injury of blood vessels at lower leg level	0.543	0.456
S84 Injury of nerves at lower leg level	0.543	0.456
J41 Simple and mucopurulent chronic bronchitis	0.543	0.457
J46 Status asthmaticus	0.543	0.457
T78 Adverse effects, not elsewhere classified	0.541	0.459
S30 Superficial injury of abdomen, lower back and pelvis	0.540	0.460
E10.1 With ketoacidosis	0.537	0.463
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.536	0.464
D75.1 Secondary polycythaemia	0.535	0.465
S22 Fracture of rib(s), sternum and thoracic spine	0.534	0.465
D22.0 Melanocytic naevi of lip	0.534	0.466
K70-K77 Diseases of liver	0.533	0.467
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.533	0.467
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.532	0.468
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.532	0.468
C78.4 Secondary malignant neoplasm of small intestine	0.532	0.468
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.532	0.468
C78.1 Secondary malignant neoplasm of mediastinum	0.532	0.468
H36 Retinal disorders in diseases classified elsewhere	0.530	0.470
F00-F09 Organic, including symptomatic, mental disorders	0.529	0.471
C43-C44 Melanoma and other malignant neoplasms of skin	0.529	0.471
H43-H45 Disorders of vitreous body and globe	0.529	0.471
H50 Other strabismus	0.529	0.471
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.527	0.473
C79 Secondary malignant neoplasm of other sites	0.527	0.473
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.526	0.474
D67 Hereditary factor IX deficiency	0.526	0.474
D66 Hereditary factor VIII deficiency	0.526	0.474
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.526	0.474
J81 Pulmonary oedema	0.526	0.474
H52.3 Anisometropia and aniseikonia	0.525	0.474
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.525	0.475
S82.80 Fractures of other parts of lower leg (closed)	0.525	0.475
D64.8 Other specified anaemias	0.525	0.475
D64.4 Congenital dyserythropoietic anaemia	0.525	0.475
D64.3 Other sideroblastic anaemias	0.525	0.475
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.525	0.475
D64.1 Secondary sideroblastic anaemia due to disease	0.525	0.475
D64.0 Hereditary sideroblastic anaemia	0.525	0.475
D09.0 Bladder	0.524	0.476
J00-J06 Acute upper respiratory infections	0.523	0.477
J43.9 Emphysema, unspecified	0.522	0.478
H52.1 Myopia	0.520	0.480
D73.0 Hyposplenism	0.520	0.480
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.520	0.480
C78.7 Secondary malignant neoplasm of liver	0.519	0.480
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.519	0.481
S51 Open wound of forearm	0.518	0.482
J99 Respiratory disorders in diseases classified elsewhere	0.518	0.482
J96 Respiratory failure, not elsewhere classified	0.518	0.482
D23.9 Skin, unspecified	0.517	0.483
D23.4 Skin of scalp and neck	0.517	0.483
D23.2 Skin of ear and external auricular canal	0.517	0.483
D23.0 Skin of lip	0.517	0.483
E13 Other specified diabetes mellitus	0.516	0.484
E12 Malnutrition-related diabetes mellitus	0.516	0.484
E15 Nondiabetic hypoglycaemic coma	0.515	0.485
S42 Fracture of shoulder and upper arm	0.513	0.487
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.512	0.488
D22.4 Melanocytic naevi of scalp and neck	0.512	0.488
E00-E07 Disorders of thyroid gland	0.512	0.488
H53 Visual disturbances	0.512	0.488
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.511	0.488
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.511	0.488
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.511	0.488
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.511	0.488
T46 Poisoning by agents primarily affecting the cardiovascular system	0.511	0.488
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.511	0.488
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.511	0.488
T41 Poisoning by anaesthetics and therapeutic gases	0.511	0.488
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.511	0.488
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.511	0.488
T36 Poisoning by systemic antibiotics	0.511	0.488
S62 Fracture at wrist and hand level	0.511	0.489
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.509	0.490
D84 Other immunodeficiencies	0.509	0.490
D83 Common variable immunodeficiency	0.509	0.490
D82 Immunodeficiency associated with other major defects	0.509	0.490
D81 Combined immunodeficiencies	0.509	0.490
D80 Immunodeficiency with predominantly antibody defects	0.509	0.490
E27 Other disorders of adrenal gland	0.508	0.492
S69 Other and unspecified injuries of wrist and hand	0.507	0.493
S67 Crushing injury of wrist and hand	0.507	0.493
S65 Injury of blood vessels at wrist and hand level	0.507	0.493
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.507	0.493
S60 Superficial injury of wrist and hand	0.507	0.493
F99-F99 Unspecified mental disorder	0.507	0.493
J13 Pneumonia due to Streptococcus pneumoniae	0.507	0.493
S01 Open wound of head	0.506	0.494
H91 Other hearing loss	0.506	0.494
S64 Injury of nerves at wrist and hand level	0.505	0.494
T85 Complications of other internal prosthetic devices, implants and grafts	0.504	0.496
E86 Volume depletion	0.504	0.496
H25-H28 Disorders of lens	0.504	0.496
C50-C50 Malignant neoplasm of breast	0.503	0.497
T43.2 Other and unspecified antidepressants	0.503	0.497
J98.1 Pulmonary collapse	0.503	0.497
H54 Blindness and low vision	0.502	0.498
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.502	0.498
C38 Malignant neoplasm of heart, mediastinum and pleura	0.502	0.498
C32 Malignant neoplasm of larynx	0.502	0.498
C31 Malignant neoplasm of accessory sinuses	0.502	0.498
C30 Malignant neoplasm of nasal cavity and middle ear	0.502	0.498
C37 Malignant neoplasm of thymus	0.502	0.498
C33 Malignant neoplasm of trachea	0.502	0.498
S49 Other and unspecified injuries of shoulder and upper arm	0.501	0.499
S48 Traumatic amputation of shoulder and upper arm	0.501	0.499
S46 Injury of muscle and tendon at shoulder and upper arm level	0.501	0.499
S45 Injury of blood vessels at shoulder and upper arm level	0.501	0.499
S44 Injury of nerves at shoulder and upper arm level	0.501	0.499
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.501	0.499
S41 Open wound of shoulder and upper arm	0.501	0.499
S47 Crushing injury of shoulder and upper arm	0.501	0.499
Q20-Q28 Congenital malformations of the circulatory system	0.501	0.499
K65 Peritonitis	0.500	0.500
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.500	0.500
Y35-Y36 Legal intervention and operations of war	0.500	0.500
Y10-Y34 Event of undetermined intent	0.500	0.500
Y00-Y09 Assault	0.500	0.500
X85-X99 Assault	0.500	0.500
X60-X84 Intentional self-harm	0.500	0.500
X58-X59 Accidental exposure to other and unspecified factors	0.500	0.500
X50-X57 Overexertion, travel and privation	0.500	0.500
X40-X49 Accidental poisoning by and exposure to noxious substances	0.500	0.500
X30-X39 Exposure to forces of nature	0.500	0.500
X20-X29 Contact with venomous animals and plants	0.500	0.500
X10-X19 Contact with heat and hot substances	0.500	0.500
X00-X09 Exposure to smoke, fire and flames	0.500	0.500
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.500	0.500
W75-W84 Other accidental threats to breathing	0.500	0.500
W65-W74 Accidental drowning and submersion	0.500	0.500
W50-W64 Exposure to animate mechanical forces	0.500	0.500
W20-W49 Exposure to inanimate mechanical forces	0.500	0.500
V98-V99 Other and unspecified transport accidents	0.500	0.500
V95-V97 Air and space transport accidents	0.500	0.500
V90-V94 Water transport accidents	0.500	0.500
V80-V89 Other land transport accidents	0.500	0.500
V70-V79 Bus occupant injured in transport accident	0.500	0.500
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.500	0.500
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.500	0.500
V40-V49 Car occupant injured in transport accident	0.500	0.500
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.500	0.500
V20-V29 Motorcycle rider injured in transport accident	0.500	0.500
V10-V19 Pedal cyclist injured in transport accident	0.500	0.500
V01-V09 Pedestrian injured in transport accident	0.500	0.500
H34 Retinal vascular occlusions	0.499	0.501
H32 Chorioretinal disorders in diseases classified elsewhere	0.499	0.501
H31 Other disorders of choroid	0.499	0.501
H30 Chorioretinal inflammation	0.499	0.501
H51 Other disorders of binocular movement	0.499	0.501
H49 Paralytic strabismus	0.499	0.501
D51 Vitamin B12 deficiency anaemia	0.499	0.501
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.499	0.501
D46 Myelodysplastic syndromes	0.499	0.501
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.499	0.501
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.499	0.501
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.499	0.501
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.499	0.501
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.499	0.501
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.499	0.501
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.499	0.501
D45 Polycythaemia vera	0.499	0.501
E10.9 Without complications	0.498	0.502
J82 Pulmonary eosinophilia, not elsewhere classified	0.498	0.502
Y60-Y69 Misadventures to patients during surgical and medical care	0.497	0.502
K00-K14 Diseases of oral cavity, salivary glands and jaws	0.498	0.502
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.497	0.503
S66 Injury of muscle and tendon at wrist and hand level	0.497	0.503
C15-C26 Malignant neoplasms of digestive organs	0.496	0.504
S00 Superficial injury of head	0.494	0.505
T65 Toxic effect of other and unspecified substances	0.494	0.506
T63 Toxic effect of contact with venomous animals	0.494	0.506
T62 Toxic effect of other noxious substances eaten as food	0.494	0.506
T61 Toxic effect of noxious substances eaten as seafood	0.494	0.506
T60 Toxic effect of pesticides	0.494	0.506
T59 Toxic effect of other gases, fumes and vapours	0.494	0.506
T57 Toxic effect of other inorganic substances	0.494	0.506
T56 Toxic effect of metals	0.494	0.506
T54 Toxic effect of corrosive substances	0.494	0.506
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.494	0.506
T52 Toxic effect of organic solvents	0.494	0.506
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.494	0.506
T58 Toxic effect of carbon monoxide	0.494	0.506
T55 Toxic effect of soaps and detergents	0.494	0.506
D18.0 Haemangioma, any site	0.493	0.507
E88 Other metabolic disorders	0.492	0.508
T75 Effects of other external causes	0.490	0.510
T74 Maltreatment syndromes	0.490	0.510
T73 Effects of other deprivation	0.490	0.510
T70 Effects of air pressure and water pressure	0.490	0.510
T69 Other effects of reduced temperature	0.490	0.510
T67 Effects of heat and light	0.490	0.510
T71 Asphyxiation	0.490	0.510
T68 Hypothermia	0.490	0.510
T66 Unspecified effects of radiation	0.490	0.510
E14 Unspecified diabetes mellitus	0.487	0.513
S29 Other and unspecified injuries of thorax	0.487	0.513
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.487	0.513
S27 Injury of other and unspecified intrathoracic organs	0.487	0.513
S26 Injury of heart	0.487	0.513
S25 Injury of blood vessels of thorax	0.487	0.513
S24 Injury of nerves and spinal cord at thorax level	0.487	0.513
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.487	0.513
S21 Open wound of thorax	0.487	0.513
S20 Superficial injury of thorax	0.487	0.513
T43.5 Other and unspecified antipsychotics and neuroleptics	0.487	0.513
H33 Retinal detachments and breaks	0.486	0.514
H80-H83 Diseases of inner ear	0.485	0.514
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.485	0.515
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.485	0.515
S37 Injury of urinary and pelvic organs	0.485	0.515
S36 Injury of intra-abdominal organs	0.485	0.515
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.485	0.515
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.485	0.515
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.485	0.515
S31 Open wound of abdomen, lower back and pelvis	0.485	0.515
D69.6 Thrombocytopenia, unspecified	0.484	0.516
Chapter XV Pregnancy, childbirth and the puerperium	0.484	0.516
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.482	0.517
D22.9 Melanocytic naevi, unspecified	0.482	0.518
D22.2 Melanocytic naevi of ear and external auricular canal	0.482	0.518
D22.1 Melanocytic naevi of eyelid, including canthus	0.482	0.518
J84 Other interstitial pulmonary diseases	0.480	0.520
D22.5 Melanocytic naevi of trunk	0.479	0.520
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.479	0.521
Q80-Q89 Other congenital malformations	0.479	0.521
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.479	0.521
Q60-Q64 Congenital malformations of the urinary system	0.479	0.521
Q50-Q56 Congenital malformations of genital organs	0.479	0.521
Q38-Q45 Other congenital malformations of the digestive system	0.479	0.521
Q35-Q37 Cleft lip and cleft palate	0.479	0.521
Q30-Q34 Congenital malformations of the respiratory system	0.479	0.521
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.479	0.521
Q00-Q07 Congenital malformations of the nervous system	0.479	0.521
S02 Fracture of skull and facial bones	0.478	0.522
D22.7 Melanocytic naevi of lower limb, including hip	0.478	0.522
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.478	0.522
D50 Iron deficiency anaemia	0.477	0.523
D18.1 Lymphangioma, any site	0.477	0.523
E61 Deficiency of other nutrient elements	0.476	0.524
D53 Other nutritional anaemias	0.476	0.524
D52 Folate deficiency anaemia	0.476	0.524
D61.8 Other specified aplastic anaemias	0.475	0.524
D61.3 Idiopathic aplastic anaemia	0.475	0.524
D61.2 Aplastic anaemia due to other external agents	0.475	0.524
D61.1 Drug-induced aplastic anaemia	0.475	0.524
D61.0 Constitutional aplastic anaemia	0.475	0.524
H35.0 Background retinopathy and retinal vascular changes	0.475	0.525
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.474	0.526
F80-F89 Disorders of psychological development	0.474	0.526
F70-F79 Mental retardation	0.474	0.526
F60-F69 Disorders of adult personality and behaviour	0.474	0.526
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.474	0.526
T39.1 4-Aminophenol derivatives	0.474	0.526
E87 Other disorders of fluid, electrolyte and acid-base balance	0.473	0.527
D75.9 Disease of blood and blood-forming organs, unspecified	0.473	0.527
D75.8 Other specified diseases of blood and blood-forming organs	0.473	0.527
D75.2 Essential thrombocytosis	0.473	0.527
D75.0 Familial erythrocytosis	0.473	0.527
S59 Other and unspecified injuries of forearm	0.473	0.527
S58 Traumatic amputation of forearm	0.473	0.527
S57 Crushing injury of forearm	0.473	0.527
S56 Injury of muscle and tendon at forearm level	0.473	0.527
S55 Injury of blood vessels at forearm level	0.473	0.527
S54 Injury of nerves at forearm level	0.473	0.527
S53 Dislocation, sprain and strain of joints and ligaments of elbow	0.473	0.527
S50 Superficial injury of forearm	0.473	0.527
E23 Hypofunction and other disorders of pituitary gland	0.473	0.527
S08 Traumatic amputation of part of head	0.472	0.527
S07 Crushing injury of head	0.472	0.527
S06 Intracranial injury	0.472	0.527
S05 Injury of eye and orbit	0.472	0.527
S04 Injury of cranial nerves	0.472	0.527
S03 Dislocation, sprain and strain of joints and ligaments of head	0.472	0.527
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.472	0.528
T93 Sequelae of injuries of lower limb	0.471	0.528

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations